Brief: Eton Pharmaceuticals Under Deal Terms Paid Seller $0.15 mln For Acquisition And Assumed $0.5 mln Of Cure Amounts Owed To Manufacturer
04/10/2023 12:03
Oct 4 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS - UNDER DEAL TERMS, ETON PAID SELLER
$0.15
MILLION FOR ACQUISITION AND ASSUMED $0.5 MILLION OF CURE AMOUNTS
OWED TO MANUFACTURER
* ETON PHARMACEUTICALS INC - ETON WILL RETAIN 80% OF PRODUCT
PROFIT AND WILL PAY 20% OF PRODUCT PROFIT TO MANUFACTURER
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer